8-K//Current report
Ambrx Biopharma Cayman, Inc. 8-K
Accession 0001193125-23-254549
CIK 0001836056operating
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 6:04 AM ET
Size
553.4 KB
Accession
0001193125-23-254549
Documents
- 8-Kd559822d8k.htmPrimary
8-K
- EX-3.1d559822dex31.htm
EX-3.1
- EX-3.2d559822dex32.htm
EX-3.2
- EX-10.1d559822dex101.htm
EX-10.1
- EX-101.SCHamam-20231011.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.DEFamam-20231011_def.xml
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
- EX-101.LABamam-20231011_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREamam-20231011_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLd559822d8k_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-23-254549-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Ambrx Biopharma Cayman, Inc.
CIK 0001836056
Entity typeoperating
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001836056
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 6:04 AM ET
- Size
- 553.4 KB